Therapy management development platform

• US 9,089,643 B2
• Filed: 11/20/2012
• Issued: 07/28/2015
• Est. Priority Date: 04/14/2009
• Status: Active Grant

• Current Assignee: Baxter Healthcare SA (Baxter International Inc.), Baxter International Inc.
• Original Assignee: Baxter Healthcare SA (Baxter International Inc.), Baxter International Inc.
• Inventors: Krogh, Ross G., Martucci, James P.
• Primary Examiner(s): FLICK, JASON E
• Application Number:
  US13/682,573
• Publication Number:
  US 20130079710A1
• Time in Patent Office: 980 Days
• Field of Search: 604/151
• US Class Current: 1/1
• CPC Class Codes: A61M 5/172 electrical or electronic A61M5/16804, A61M5/16831 take precedence
• CPC Class Codes: G16H 10/20 for electronic clinical trials or questionnaires
• CPC Class Codes: G16H 20/17 delivered via infusion or injection
• CPC Class Codes: G16H 40/60 for the operation of medical equipment or devices
• CPC Class Codes: G16H 40/63 for local operation

Abstract

A therapy management development platform includes a pump controller coupled to an interface module. The interface module includes an interface module controller and a module-sensor input/output interface including at least one standardized input port, output port and power connection. The interface module is also customizably programmed to receive data from a sensor and to provide instructions to the pump controller to vary the operation of a pump coupled thereto according to one of a plurality of levels of functionality. Upon receipt of an indication of approval from a remote computer to change the level of access to the functionality of the platform, the interface module may be customizably programmed to receive different data from the sensor, to provide different instructions to the pump controller, or both, the approval corresponding to a stage in testing of a medical device.

Claims

1. A therapy management development platform comprising:

a pump controller comprising a processor and memory; and

an interface module including an interface module controller comprising a processor and memory, and a module-sensor input/output interface comprising at least one standardized input port, at least one standardized output port and at least one standardized power connection,

the interface module coupled to the pump controller,

the interface module customizably programmed to receive data from a sensor coupled to the module-sensor input/output interface and to provide instructions to the pump controller to vary the operation of a pump coupled thereto according to one of a plurality of levels of functionality,

wherein upon receipt of an indication of approval from a remote computer to change the level of access to the functionality of the platform, the interface module may be customizably programmed to receive different data from the sensor, to provide different instructions to the pump controller to vary the operation of the pump, or both, the approval corresponding to a stage in testing of a medical device, the stage comprising one of bench trials, animal trials, human clinical trials and human use.

2. The therapy management development platform according to claim 1, further comprising a computing device coupled to the interface module controller, and comprising a development toolkit having a graphical user interface to customizably program the interface module controller.

3. The method according to claim 2, wherein the toolkit comprises a standardized library of commands.

4. The therapy management development platform according to claim 1, wherein the indication of approval to change the level of access to functionality of the platform corresponds to a password, the interface module controller programmed to change the level of access to functionality in response to receipt of the password from the remote computer.

5. The therapy management development platform according to claim 1, wherein the indication of approval to change the level of access to functionality of the platform corresponds to an encryption key, the interface module programmed to change the level of access to functionality in response to receipt of the encryption key from the remote computer.

6. The therapy management development platform according to claim 1, wherein the remote computer is coupled to the interface module via a wireless connection.

7. The therapy management development platform according to claim 1, wherein the remote computer is coupled to the interface module via a hardwired connection.

8. The therapy management development platform according to claim 1, wherein the remote computer is coupled to the interface module via a transportable memory device.

9. The therapy management development platform according to claim 8, wherein the pump controller is coupled to the interface module controller via radio-frequency or infra-red transmission.